Physician Wealth Advisors Inc. recently increased its holdings in the iShares U.S. Equity Factor ETF by 2.4%, according to a new SEC filing. This purchase involved an additional 925 shares during the second quarter, bringing the total to 39,249.
iShares U.S. Equity Factor ETF $LRGF Shares Purchased by Physician Wealth Advisors Inc.

Key Takeaways:
- Physician Wealth Advisors Inc. increased its LRGF holdings by 2.4%.
- 925 additional shares were acquired in the second quarter.
- The firm now holds 39,249 shares of the ETF.
- The data is based on a Form 13F filing with the SEC.
- The article was originally published by The Lincolnian Online.
Expanded Holdings in LRGF
Physician Wealth Advisors Inc. recently disclosed in its most recent Form 13F filing with the U.S. Securities and Exchange Commission that it has increased its stake in the iShares U.S. Equity Factor ETF (NYSEARCA: LRGF). The firm boosted its holdings by 2.4% during the second quarter, reflecting a measured but noteworthy move in its investment approach.
Insights from the SEC Filing
According to the filing, the investment firm added 925 shares of the ETF over this period. By the end of the second quarter, Physician Wealth Advisors Inc. reported holding a total of 39,249 shares. The detailed Form 13F filing underscores the incremental yet meaningful shift in the firm’s portfolio.
About the iShares U.S. Equity Factor ETF
The iShares U.S. Equity Factor ETF, traded under the ticker LRGF on NYSEARCA, employs a multifactor investment strategy. Though the newly filed report does not elaborate on performance details, the ETF is often considered by institutions seeking broad-based yet factor-focused equity exposure.
Why This Matters to Investors
The data from institutional filings such as Form 13F can offer insights into how professional firms adjust their holdings. For Physician Wealth Advisors Inc., the move to expand its stake in LRGF signals confidence in this ETF’s investment approach. While the filing does not provide further analysis, it documents a notable growth in the firm’s portfolio allocation.